Mike Matson
Stock Analyst at Needham
(2.48)
# 1,455
Out of 4,496 analysts
358
Total ratings
50.16%
Success rate
-2%
Average return
Main Sectors:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NARI Inari Medical | Downgrades: Hold | n/a | $54.90 | - | 5 | Jul 18, 2024 | |
| INMD InMode | Reiterates: Hold | n/a | $17.69 | - | 13 | Jul 11, 2024 | |
| MASI Masimo | Reiterates: Hold | n/a | $106.76 | - | 15 | Jul 9, 2024 | |
| ATRC AtriCure | Reiterates: Buy | $40 | $24.17 | +65.49% | 22 | Jul 8, 2024 | |
| MMSI Merit Medical Systems | Maintains: Buy | $85 → $93 | $85.49 | +8.78% | 16 | Jul 1, 2024 | |
| RMD ResMed | Reiterates: Buy | $236 | $203.15 | +16.17% | 8 | Jun 24, 2024 | |
| PSNL Personalis | Reiterates: Buy | $3.5 | $3.85 | -9.09% | 14 | Jun 21, 2024 | |
| ICUI ICU Medical | Initiates: Hold | n/a | $122.30 | - | 1 | Jun 21, 2024 | |
| BSX Boston Scientific | Reiterates: Buy | $82 | $77.56 | +5.72% | 19 | Jun 18, 2024 | |
| HAE Haemonetics | Upgrades: Buy | $112 | $88.73 | +26.23% | 8 | Jun 12, 2024 | |
| LIVN LivaNova | Reiterates: Buy | $72 | $52.91 | +36.08% | 18 | Jun 6, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | n/a | $110.50 | - | 18 | May 30, 2024 | |
| SRDX Surmodics | Downgrades: Hold | n/a | $41.66 | - | 16 | May 29, 2024 | |
| MDT Medtronic | Reiterates: Hold | n/a | $79.48 | - | 8 | May 24, 2024 | |
| SYK Stryker | Upgrades: Buy | $392 | $340.95 | +14.97% | 2 | May 22, 2024 | |
| OCX OncoCyte | Reiterates: Buy | $4.25 | $3.21 | +32.40% | 12 | May 16, 2024 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $0.84 | +197.69% | 14 | May 13, 2024 | |
| STE STERIS | Reiterates: Hold | n/a | $224.29 | - | 8 | May 10, 2024 | |
| FNA Paragon 28 | Maintains: Buy | $17 → $14 | $8.10 | +72.84% | 12 | May 9, 2024 | |
| PEN Penumbra | Reiterates: Hold | n/a | $189.87 | - | 6 | May 8, 2024 | |
| VCYT Veracyte | Maintains: Buy | $33 → $27 | $23.18 | +16.48% | 11 | May 8, 2024 | |
| INGN Inogen | Reiterates: Hold | n/a | $9.25 | - | 10 | May 8, 2024 | |
| KIDS OrthoPediatrics | Maintains: Buy | $37 → $42 | $32.57 | +28.95% | 14 | May 7, 2024 | |
| AORT Artivion | Maintains: Buy | $25 → $30 | $27.22 | +10.21% | 11 | May 7, 2024 | |
| AXNX Axonics | Reiterates: Hold | n/a | $67.72 | - | 17 | May 6, 2024 | |
| CNMD CONMED | Reiterates: Buy | $107 | $70.96 | +50.79% | 17 | May 6, 2024 | |
| TFX Teleflex | Reiterates: Hold | n/a | $221.79 | - | 6 | May 3, 2024 | |
| ENOV Enovis | Reiterates: Buy | $82 | $46.71 | +75.55% | 9 | May 3, 2024 | |
| HOLX Hologic | Reiterates: Buy | $90 | $78.11 | +15.22% | 9 | May 3, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $24 → $19 | $14.51 | +30.94% | 17 | Apr 30, 2024 | |
| SIBN SI-BONE | Maintains: Buy | n/a | $16.61 | - | 1 | Mar 9, 2021 | |
| GMED Globus Medical | Maintains: Buy | n/a | $72.63 | - | 1 | Feb 18, 2021 |
Inari Medical
Jul 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $54.90
Upside: -
InMode
Jul 11, 2024
Reiterates: Hold
Price Target: n/a
Current: $17.69
Upside: -
Masimo
Jul 9, 2024
Reiterates: Hold
Price Target: n/a
Current: $106.76
Upside: -
AtriCure
Jul 8, 2024
Reiterates: Buy
Price Target: $40
Current: $24.17
Upside: +65.49%
Merit Medical Systems
Jul 1, 2024
Maintains: Buy
Price Target: $85 → $93
Current: $85.49
Upside: +8.78%
ResMed
Jun 24, 2024
Reiterates: Buy
Price Target: $236
Current: $203.15
Upside: +16.17%
Personalis
Jun 21, 2024
Reiterates: Buy
Price Target: $3.5
Current: $3.85
Upside: -9.09%
ICU Medical
Jun 21, 2024
Initiates: Hold
Price Target: n/a
Current: $122.30
Upside: -
Boston Scientific
Jun 18, 2024
Reiterates: Buy
Price Target: $82
Current: $77.56
Upside: +5.72%
Haemonetics
Jun 12, 2024
Upgrades: Buy
Price Target: $112
Current: $88.73
Upside: +26.23%
LivaNova
Jun 6, 2024
Reiterates: Buy
Price Target: $72
Current: $52.91
Upside: +36.08%
Zimmer Biomet Holdings
May 30, 2024
Reiterates: Hold
Price Target: n/a
Current: $110.50
Upside: -
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $41.66
Upside: -
Medtronic
May 24, 2024
Reiterates: Hold
Price Target: n/a
Current: $79.48
Upside: -
Stryker
May 22, 2024
Upgrades: Buy
Price Target: $392
Current: $340.95
Upside: +14.97%
OncoCyte
May 16, 2024
Reiterates: Buy
Price Target: $4.25
Current: $3.21
Upside: +32.40%
Lucid Diagnostics
May 13, 2024
Reiterates: Buy
Price Target: $2.5
Current: $0.84
Upside: +197.69%
STERIS
May 10, 2024
Reiterates: Hold
Price Target: n/a
Current: $224.29
Upside: -
Paragon 28
May 9, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $8.10
Upside: +72.84%
Penumbra
May 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $189.87
Upside: -
Veracyte
May 8, 2024
Maintains: Buy
Price Target: $33 → $27
Current: $23.18
Upside: +16.48%
Inogen
May 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.25
Upside: -
OrthoPediatrics
May 7, 2024
Maintains: Buy
Price Target: $37 → $42
Current: $32.57
Upside: +28.95%
Artivion
May 7, 2024
Maintains: Buy
Price Target: $25 → $30
Current: $27.22
Upside: +10.21%
Axonics
May 6, 2024
Reiterates: Hold
Price Target: n/a
Current: $67.72
Upside: -
CONMED
May 6, 2024
Reiterates: Buy
Price Target: $107
Current: $70.96
Upside: +50.79%
Teleflex
May 3, 2024
Reiterates: Hold
Price Target: n/a
Current: $221.79
Upside: -
Enovis
May 3, 2024
Reiterates: Buy
Price Target: $82
Current: $46.71
Upside: +75.55%
Hologic
May 3, 2024
Reiterates: Buy
Price Target: $90
Current: $78.11
Upside: +15.22%
NeoGenomics
Apr 30, 2024
Maintains: Buy
Price Target: $24 → $19
Current: $14.51
Upside: +30.94%
SI-BONE
Mar 9, 2021
Maintains: Buy
Price Target: n/a
Current: $16.61
Upside: -
Globus Medical
Feb 18, 2021
Maintains: Buy
Price Target: n/a
Current: $72.63
Upside: -